Insulin glargine not a cancer risk: guide

GPs who prescribe insulin glargine should feel “completely and utterly” at ease that it does not increase the risk of cancer, according to new guidance from the Australian Diabetes Society.

The endorsement, based on a reassuring study in the New England Journal of Medicine this year brings clarity three years after a controversial European study suggested a link between the drug and breast cancer.

In a

Latest

Trending